PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
| Autor: | Reni, M. a, ⁎, Cereda, S. a, Galli, L. b |
|---|---|
| Zdroj: | In Cancer Letters 2007 256(1):25-28 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect